GLIOBLASTOMAS

Clinical trials for GLIOBLASTOMAS explained in plain language.

Never miss a new study

Get alerted when new GLIOBLASTOMAS trials appear

Sign up with your email to follow new studies for GLIOBLASTOMAS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New drug targets deadly brain cancer that has returned

Disease control Not yet recruiting

This early-phase trial tests an experimental drug called LMP744 in 40 adults whose glioblastoma (a fast-growing brain cancer) has come back after standard treatment. The drug is given through a vein for 5 days in a row each month for up to a year. The goal is to see if it can shr…

Matched conditions: GLIOBLASTOMAS

Phase: PHASE1, PHASE2 • Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) • Aim: Disease control

Last updated May 04, 2026 16:19 UTC

GLIOBLASTOMAS

Get alerted when new GLIOBLASTOMAS trials appear

New drug targets deadly brain cancer that has returned